Kathleen E. Walsh's most recent trade in Beam Therapeutics Inc was a trade of 23,114 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Beam Therapeutics Inc | Kathleen E. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 23,114 | 23,114 | - | - | Stock Option (Right to Buy) | |
Beam Therapeutics Inc | Kathleen E. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,532 | 16,532 | - | - | Stock Option (Right to Buy) | |
LifeMD Inc | Kathleen E. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 75,000 | 75,000 | - | - | Common Stock | |
LifeMD Inc | Kathleen E. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
Beam Therapeutics Inc | Kathleen E. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 10,391 | 10,391 | - | - | Stock Option (Right to Buy) | |
Beam Therapeutics Inc | Kathleen E. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 3,126 | 3,126 | - | - | Stock Option (Right to Buy) | |
Beam Therapeutics Inc | Kathleen E. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2021 | 11,609 | 11,609 | - | - | Stock Option (Right to Buy) |